Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10556943 HLA-DR binding peptides and their uses

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 16, 2016
Date of Patent
February 11, 2020
Patent Application Number
15381454
Patent Citations Received
‌
US Patent 12091443 Method of compact peptide vaccines using residue optimization
0
‌
US Patent 11464842 Compositions and method for optimized peptide vaccines using residue optimization
‌
US Patent 11981923 Pepmixes to generate multiviral CTLS with broad specificity
0
‌
US Patent 12064475 Compositions and method for optimized peptide vaccines using residue optimization
0
‌
US Patent 11464837 Immunogenic compositions comprising nucleic acids for RAS peptides
‌
US Patent 11235039 Immunogenic compositions comprising nucleic acids for RAS peptides
‌
US Patent 11672850 Compositions and method for optimized peptide vaccines using residue optimization
0
‌
US Patent 11673936 Method of compact peptide vaccines using residue optimization
0
‌
US Patent 11421015 Method of compact peptide vaccines using residue optimization
‌
US Patent 11931408 Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10556943
Patent Primary Examiner
‌
Michael Szperka

Find more entities like US Patent 10556943 HLA-DR binding peptides and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo